Previous Episode
Ep. 9 - IPOs, Vaccines & BIO's New Leader
Next Episode
Ep. 11 - Funding U.K. Biotechs, plus Global Vaccine Access
BioCentury This Week - Ep. 10 - EUAs, ACTIV & M&A
Transcript
Ep. 10 15JUN2020
Jeff Cranmer: Welcome to BioCentury This Week. I'm Jeff Cranmer, Executive Editor, BioCentury and I'm joined by my colleagues
[00:00:07]Simone Fishburn: Simone Fishburn, Editor in Chief
[00:00:09]Steve Usdin: Steve Usdin, Washington Editor
[00:00:11]Amanda Micklus: Amanda Micklus, Senior Biopharma Analyst
[00:00:14]Jeff Cranmer: Amanda will be discussing her analysis of M&A momentum in the face of the COVID-19 crisis, a l
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/biocentury-this-week-290590/ep-10-euas-activ-and-m-and-a-37949163"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to ep. 10 - euas, activ & m&a on goodpods" style="width: 225px" /> </a>
Copy